Amin Makarem

Stock Analyst at Jefferies

(2.07)
# 3,273
Out of 4,988 analysts
2
Total ratings
50%
Success rate
44.8%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Amin Makarem

UroGen Pharma
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $43.25
Upside: -7.51%
Foghorn Therapeutics
Feb 16, 2026
Reiterated: Buy
Price Target: $12
Current: $4.14
Upside: +189.86%